Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
Abstract Background Intracellular deposition of alpha‐synuclein (α‐syn) as Lewy bodies and Lewy neurites is a central event in the pathogenesis of Parkinson's disease (PD) and other α‐synucleinopathies. Transgenic mouse models overexpressing human α‐syn, are useful research tools in preclinical...
Main Authors: | Agata Aniszewska, Joakim Bergström, Martin Ingelsson, Sara Ekmark‐Lewén |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2628 |
Similar Items
-
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form
by: Timothy J. Collier, et al.
Published: (2017-10-01) -
Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils
by: S. Ekmark-Lewén, et al.
Published: (2023-01-01) -
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
by: Louise Berkhoudt Lassen, et al.
Published: (2022-11-01) -
Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01) -
Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
by: Stephanie Lohmann, et al.
Published: (2022-02-01)